| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.8 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.013 | 0.8 |